Insights from 2023 ASH Annual Meeting


 

ASH 2023 Insights: "Clinical Outcomes Among Patients on Apixaban, Rivaroxaban, and Warfarin For AFib and/or VTE"

39 views
December 17, 2023
0 Comments
Login to view comments. Click here to Login
Benign Hematology